Los Angeles, California, United StatesFounded 201770+ employeesPrivate
$115M raisedSeries A· last: series b (Apr 2022)· 3 rounds
Backed by(18 investors)
Octant is a well-backed team of experienced technologists and entrepreneurs navigating the complexity of biology and chemistry to develop next generation small molecules. Combining advanced cell engineering, high-throughput chemistry, and automation we are engineering best-in-class drugs across rare disease, oncology, and immunology.
Founders
Open Positions at Octant (2 Jobs)
2 open · 2 filled
